Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely orciprenaline 20 milligram/1 each conventional release oral tablet |
Is a |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Orciprenaline sulfate 10mg/5mL syrup |
Is a |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Metaproterenol sulfate 0.4%/2.5mL inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Metaproterenol sulfate 0.6%/2.5mL inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Product containing precisely orciprenaline sulfate 50 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Metaproterenol sulfate 50mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Metaproterenol sulfate 10mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Metaproterenol sulfate 15mg/mL aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Metaproterenol sulfate 0.65mg/inh aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orciprenaline sulfate |
Inferred relationship |
Some |
|
Orciprenaline sulfate 2 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |
Orciprenaline sulfate 2 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |
Orciprenaline sulfate 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |
Orciprenaline sulfate 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely orciprenaline sulfate 50 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely orciprenaline sulfate 50 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Orciprenaline sulfate |
Inferred relationship |
Some |
1 |